Sexuality of Women With Pelvic Cancer

NCT04070950 | Completed

• 1 other identifier: CHUBX 2008/39
• Study Type: observational
• Target: 40
• Locations: 1 country
• Sites: 1

Brief Summary

This study aims to study in patients with cancer of the cervix or the body of the uterus, or the ovary between the time of diagnosis and 3 months after the end of the last treatment: the evolution of the relationship of couple, and more particularly of communication (verbal and non-verbal) concerning sexuality, before and during cancer.

Conditions

Sexual Behavior; Pelvic Cancer

Outcome Measures

Primary Outcomes (1)

• Evaluation of sexual activity

  Questionnaire SAQ : Sexual Activity Questionnaire, contains 21 items divided into three parts: the first part allows to know if a woman is sexually active or not, the second part allows to define the reasons for this activity or its absence. The third part of the questionnaire filled out by sexually active women aims to explore the pleasure generated by sex (desire, satisfaction, frequency), discomfort during intercourse, especially due to vaginal dryness and pain as well as the habits of the patient before the illness.

  3 months after the end of therapeutic treatment (not the object of the study)

Study Arms (1)

Single group

Interview of patients with cancer of the cervix or uterine body, or ovary between the time of diagnosis and 3 months after the end of their last cancer treatment (not the object of the study).

Other: Questionnaires

Interventions

Questionnaires OTHER

Two self-questionnaires

Single group

Eligibility Criteria

• Age: 18 Years+
• Gender Eligibility Details: Women with cancer of the cervix or uterine body, or ovarian
• Healthy Volunteers: No
• Age Groups: Adult (18-64), Older Adult (65+)
• Sampling Method: Non-Probability Sample

Study Population

Women with cancer of the cervix or uterine body, or ovarian

You may qualify if:

• Age ≥ 18 years
• Life in a couple or single with a regular partner for at least 3 months
• Cancer of the cervix or uterine body or ovarian cancer, in first diagnosis and treatment
• Whatever the stage of cancer
• Curative treatment
• Support in one of the participating centers
• Possible follow-up of all stages of the research

You may not qualify if:

• Presence of metastases
• History of other cancer
• History of severe psychiatric illness

Sponsors & Collaborators

• University Hospital, Bordeaux: lead

Study Sites (1)

Unknown Facility

Bordeaux, France

Location

Related Publications (1)

• Giacomoni C, Venturini E, Hoarau H, Guyon F, Conri V. How women with gynaecological cancer deal with treatment: issues of visibility and invisibility. Gynecol Obstet Fertil. 2014 Nov;42(11):795-9. doi: 10.1016/j.gyobfe.2014.09.013. Epub 2014 Oct 19.

  PMID: 25444701 RESULT

MeSH Terms

Conditions

Sexual Behavior; Pelvic Neoplasms

Interventions

Surveys and Questionnaires

Condition Hierarchy (Ancestors)

Behavior; Neoplasms by Site; Neoplasms

Intervention Hierarchy (Ancestors)

Data Collection; Epidemiologic Methods; Investigative Techniques; Health Care Evaluation Mechanisms; Quality of Health Care; Health Care Quality, Access, and Evaluation; Public Health; Environment and Public Health

Study Officials

• Alain RAVAUD

  University Hospital, Bordeaux

  PRINCIPAL INVESTIGATOR

Study Design

• Study Type: observational
• Observational Model: COHORT
• Time Perspective: PROSPECTIVE
• Sponsor Type: OTHER
• Responsible Party: SPONSOR

Study Record Dates

• First Submitted: August 23, 2019
• First Posted: August 28, 2019
• Study Start: September 1, 2009
• Primary Completion: May 20, 2010
• Study Completion: May 20, 2010
• Last Updated: June 10, 2026

Record last verified: 2019-08

Data Sharing

• IPD Sharing: Will not share

Locations

FR (1)